Deflazacort 6 mg, 30 mg Tablets
10 x 10 Tabs
Allergic and inflammatory disorders.
Oral corticosteroid for local use as immunosuppressant.
Systemic infection; live virus vaccines in those receiving immunosuppressive doses.
GI disturbances, musculoskeletal, endocrine, neuropsychiatric, ophthalmic, fluid and electrolyte disturbances; susceptible to infection, impaired healing, hypersensitivity, skin atrophy, striae, telangiectasia, acne, myocardial rupture following recent MI, thromboembolism.
Adrenal suppression and infection, child, adolescents, elderly, history of TB and steroid myopathy, hypertension, recent MI, CHF, liver failure, renal impairment, DM and glaucoma (including family history), osteoporosis, corneal perforation, severe affective disorders, epilepsy, peptic ulcer, hypothyroidism, pregnancy and lactation.
Allergic and inflammatory disorders
Adult: Initially, up to 120 mg daily. Maintenance: 3-18 mg/day.
Child: 0.25-1.5 mg/kg/day given on alternate days.
Hepatic impairment: Dose reductions may be needed.
Storage conditions :
Store protected from light and moisture, at a temperature not exceeding 30°C.